Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Iran J Kidney Dis ; 10(5): 299-303, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27721228

RESUMO

INTRODUCTION:  C-reactive protein (CRP) is increased among patients on maintenance hemodialysis. Such inflammatory markers can result in protein-energy deficit syndromes and low adequacy of dialysis in these patients. This study evaluated the effect of pentoxifylline on serum CRP level and KT/V in end-stage renal disease patients on maintenance hemodialysis. MATERIAL AND METHODS: This 1-month randomized, double-blind, placebo-controlled clinical trial involving 73 patients with end-stage renal disease on maintenance hemodialysis assessed the effectiveness of 400 mg/d of pentoxifylline on serum CRP level decrease and improvement of dialysis adequacy. RESULTS: The difference in mean serum CRP levels of the pentoxifylline and placebo groups was not significant before study. While CRP showed showed a significant increase in the placebo group after completing the interventions (P = .01), the difference was nonsignificant in the pentoxifylline group (P = .53). The difference in the mean adequacy of dialysis was not significant before the interventions between the two groups, while there was a significant increase in the pentoxifylline group (P = .01) and a nonsignificant increase in the placebo group (P = .31) after the interventions. CONCLUSIONS: Among patients on maintenance hemodialysis, a 1-month trial of pentoxifylline was associated with a substantial improvement of adequacy of dialysis and a significant prevention from serum CRP level increase, but not a significant reduction in the mean serum CRP level.


Assuntos
Proteína C-Reativa/imunologia , Sequestradores de Radicais Livres/uso terapêutico , Falência Renal Crônica/terapia , Pentoxifilina/uso terapêutico , Diálise Renal , Idoso , Nitrogênio da Ureia Sanguínea , Método Duplo-Cego , Feminino , Humanos , Falência Renal Crônica/imunologia , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
2.
Iran J Kidney Dis ; 10(5): 319-324, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27721231

RESUMO

INTRODUCTION: The purpose of this study was to explore the effect of cold dialysis on fatigue in hemodialysis patients. MATERIALS AND METHODS: In a double-blinded cross-over clinical trial, 46 participants were recruited from a hemodialysis unit in Iran. The participants were allocated into 2 groups through simple random sampling method. Each group received 3 sessions of hemodialysis with a dialysis solution temperature of either 37°C 3 or 35.5°C during the first week and then with for another week with the other temperature.  The self-report Piper Fatigue Scale questionnaire was filled out by the participants. RESULTS: The Piper Fatigue Scale scores in the cold dialysis groups were significantly lower than those in the conventional dialysis solution temperature (P < .001). Reducing the temperature of hemodialysis solution brought a 31.3% reduction in the fatigue score. CONCLUSIONS: Cold dialysis can be used for all hemodialysis patients as a routine intervention, and in particular, it is recommended dialysis patients who have severe fatigue as a convenient and inexpensive therapeutic option.


Assuntos
Crioterapia/métodos , Fadiga/terapia , Soluções para Hemodiálise , Falência Renal Crônica/terapia , Diálise Renal/métodos , Adulto , Idoso , Temperatura Baixa , Estudos Cross-Over , Método Duplo-Cego , Feminino , Humanos , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários
3.
Int J Womens Health ; 8: 203-11, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27366105

RESUMO

BACKGROUND: Marital relationships may fluctuate due to physical and psychological changes during pregnancy. This study aimed to investigate the effect of group sexual counseling on the traditional perceptions and attitudes of pregnant women. METHODS: This was a quasiexperimental intervention study. Among the pregnant women who were referred to health care centers in Zahedan, Iran, in 2015 for routine care during pregnancy, 100 individuals were chosen and randomly categorized into two groups: intervention (n=50) and control (n=50). Variables were the participant's attitudes and beliefs on sexual activity during pregnancy. The data were collected during pregnancy using the Sexual Activities and Attitudes Questionnaire. The questionnaire was completed before and 6 weeks after five sessions of group sexual counseling. Data were analyzed using SPSS software (Version 20) with descriptive and analytical statistics. RESULTS: The mean of score changes for sexual attitudes and traditional perceptions in the intervention group was significantly higher than that in the control group (P<0.0001). Analysis of covariance also showed that the mean score of the participant's traditional perceptions and sexual attitudes in both groups was significantly different after the group sexual counseling. DISCUSSION: Due to the positive effect of group sexual counseling on improving the attitudes of pregnant women about sexual issues and reframing the traditional perceptions over sexual activities during pregnancy, it is recommended that this educational intervention should be integrated into counseling and prenatal care for pregnant women.

4.
Iran J Kidney Dis ; 8(6): 461-6, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25362221

RESUMO

INTRODUCTION: This study was aimed to investigate the effects of raloxifene on intact parathyroid hormone (PTH) level and bone mineral density (BMD) for 8 months in women on hemodialysis and women with chronic kidney disease stage 5 not dependent on dialysis to determine its effect on secondary hyperparathyroidism and osteoporosis. MATERIALS AND METHODS: Fifty-one women on hemodialysis and 9 with chronic kidney disease stage 5 were randomly assigned to receive oral raloxifene, 60 mg/d, or placebo for 8 months. Baseline blood determinations and BMD were done and repeated after 8 months. Serum levels of total calcium, phosphorus, alkaline phosphatase, and intact PTH were measured. RESULTS: Serum levels of intact PTH significantly decreased in both groups, and there was no difference between the two groups after 8 months (P = .37). Serum phosphorus levels also decreased by 1.8% in the two groups. After 8 months of treatment, the BMD of the lumbar spine and femural neck decreased by 1.9% in the control group, while an increase in BMD was observed in the raloxifene group,with an average increase in both BMDs of the lumbar spine and the femural neck by 2% (significant in the lumbar spine; P = .01). CONCLUSIONS: Raloxifene has proven to be an effective medication in terms of improving BMD, with no adverse effects. However, it had no effect on controlling hyperparathyroidism in our patients. Long-term studies should be done to investigate the effects of raloxifene in chronic kidney disease and dialysis patients.


Assuntos
Conservadores da Densidade Óssea/uso terapêutico , Doenças Ósseas Metabólicas/tratamento farmacológico , Osteoporose Pós-Menopausa/tratamento farmacológico , Hormônio Paratireóideo/sangue , Cloridrato de Raloxifeno/uso terapêutico , Diálise Renal , Insuficiência Renal Crônica/complicações , Administração Oral , Fosfatase Alcalina/sangue , Densidade Óssea/efeitos dos fármacos , Cálcio/sangue , Feminino , Humanos , Hiperparatireoidismo Secundário/tratamento farmacológico , Pessoa de Meia-Idade , Fósforo/sangue , Cloridrato de Raloxifeno/administração & dosagem
5.
Iran J Kidney Dis ; 2(1): 50-2, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19367010

RESUMO

We report a case of acute renal failure related to rhabdomyolysis in a patient with Sheehan syndrome, while other diseases that could cause rhabdomyolysis were excluded. The patient's kidney function completely recovered with 3 sessions of intermittent hemodialysis. After thyroxine replacement therapy, musculoskeletal symptoms disappeared and creatine kinase concentrations decreased. Steroid replacement therapy was also administered. The present case suggests that rhabdomyolysis could occur in a patient with Sheehan syndrome without other precipitating factors.


Assuntos
Injúria Renal Aguda/etiologia , Hipopituitarismo/complicações , Rabdomiólise/complicações , Injúria Renal Aguda/terapia , Feminino , Humanos , Pessoa de Meia-Idade , Diálise Renal
6.
Med Sci Monit ; 13(2): CR100-4, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17261981

RESUMO

BACKGROUND: Hypertension is a common condition that affects many people in the world. Although several risk factors for the development of hypertension have been identified, its etiology is still not fully understood. In this study the prevalence of dyslipidemia in a hypertensive and a control group was compared and the cutoff points of the lipid profile to predict hypertension were determined. MATERIAL/METHOD: In this cross-sectional population-based study, the lipid profiles of 250 people who had hypertension were compared with those of 750 healthy subjects (control group). Total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured. Receiver operating characteristic (ROC) curves were used to determine the optimal cutoff values. RESULTS: There were significant differences in mean TC, TG, and LDL-C between the hypertensive and control groups (p<0.001). ROC curves for predicting hypertension were plotted and the best cutoff values were 185 mg/dl for TC, 125 mg/dl for TG, 110 mg/dl for LDL-C, and 45 mg/dl for HDL-C. CONCLUSION: The significantly higher prevalence of dyslipidemia in hypertensive patients may necessitate special attention to its detection and treatment. Also, plasma lipid cutoff points in hypertension seem to be different from ATP III cutoff points (for a patient with a 2+ risk factor). Further studies are needed to confirm standard values of the lipid profile as a predictive factor in hypertensive patients.


Assuntos
Hipertensão/sangue , Lipídeos/sangue , Estudos de Casos e Controles , Colesterol/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Estudos Transversais , Dislipidemias/sangue , Dislipidemias/complicações , Humanos , Hipertensão/etiologia , Irã (Geográfico) , Curva ROC , Fatores de Risco , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...